Search
Search results
717 results found
Disease burden and cost of hidradenitis suppurativa: a retrospective examination of US administrative claims data.
Marvel, Jessica, Anna Vlahiotis, Amy Sainski-Nguyen, Tina Willson, and Alexandra Kimball. 2019. “Disease Burden and Cost of Hidradenitis Suppurativa: A Retrospective Examination of US Administrative Claims Data.”. BMJ Open 9 (9): e030579.
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, intralesional, and systemic medical management.
Alikhan, Ali, Christopher Sayed, Afsaneh Alavi, Raed Alhusayen, Alain Brassard, Craig Burkhart, Karen Crowell, et al. 2019. “North American Clinical Management Guidelines for Hidradenitis Suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II: Topical, Intralesional, and Systemic Medical Management.”. Journal of the American Academy of Dermatology 81 (1): 91-101.
Online communications among hidradenitis suppurativa patients reflect community needs.
Golbari, Nicole M, Martina L Porter, and Alexa B Kimball. 2019. “Online Communications Among Hidradenitis Suppurativa Patients Reflect Community Needs.”. Journal of the American Academy of Dermatology 80 (6): 1760-62.
Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
Zouboulis, C C, F G Bechara, J L Dickinson-Blok, W Gulliver, B Horváth, R Hughes, A B Kimball, et al. 2019. “Hidradenitis Suppurativa/Acne Inversa: A Practical Framework for Treatment Optimization - Systematic Review and Recommendations from the HS ALLIANCE Working Group.”. Journal of the European Academy of Dermatology and Venereology : JEADV 33 (1): 19-31.
An assessment of the relative impact of hidradenitis suppurativa, psoriasis, and obesity on quality of life.
Storer, M A, M J Danesh, M E Sandhu, V Pascoe, and A B Kimball. 2018. “An Assessment of the Relative Impact of Hidradenitis Suppurativa, Psoriasis, and Obesity on Quality of Life.”. International Journal of Women’s Dermatology 4 (4): 198-202.
Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and II.
Kimball, Alexandra B, Thrasivoulos Tzellos, Brian M Calimlim, Henrique D Teixeira, Ziqian Geng, and Martin M Okun. 2018. “Achieving Hidradenitis Suppurativa Response Score Is Associated With Significant Improvement in Clinical and Patient-Reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and II.”. Acta Dermato-Venereologica 98 (10): 932-37.
Risks of developing psychiatric disorders in pediatric patients with psoriasis.
Kimball, Alexa B, Eric Q Wu, Annie Guérin, Andrew P Yu, Magda Tsaneva, Shiraz R Gupta, Yanjun Bao, and Parvez M Mulani. 2012. “Risks of Developing Psychiatric Disorders in Pediatric Patients With Psoriasis.”. Journal of the American Academy of Dermatology 67 (4): 651-7.e1.
The burden of autoimmune disease: a comparison of prevalence ratios in patients with psoriatic arthritis and psoriasis.
Makredes, Maryanne, Don Robinson, Mohan Bala, and Alexa B Kimball. 2009. “The Burden of Autoimmune Disease: A Comparison of Prevalence Ratios in Patients With Psoriatic Arthritis and Psoriasis.”. Journal of the American Academy of Dermatology 61 (3): 405-10.
Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002.
Kimball, A B, D Robinson, Y Wu, C Guzzo, N Yeilding, C Paramore, K Fraeman, and M Bala. 2008. “Cardiovascular Disease and Risk Factors Among Psoriasis Patients in Two US Healthcare Databases, 2001-2002.”. Dermatology (Basel, Switzerland) 217 (1): 27-37.